German vaccine maker BioNTech SE (NASDAQ:BNTX) revealed on May 20 that it intends to boost its presence in the UK with an investment of up to £1 billion ($1.33 billion) over the next decade, focusing ...
Hosted on MSN
Pfizer, BioNTech lose UK court appeal over Covid jab
LONDON, UK — US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million-pound battle against US rival Moderna over the Covid-19 vaccine.
Add Yahoo as a preferred source to see more of our stories on Google. German-based biotech company BioNTech SE is set to acquire InstaDeep, a Tunis-born and U.K.-based artificial intelligence (AI) ...
BioNTech CEO Ugur Sahin, whose company is Pfizer's vaccine partner in Europe, told reporters on Tuesday that the "likelihood" their shot would work with regards to the UK variant was "relatively high, ...
BERLIN, Feb 19 (Reuters) - Clinical trials for BioNTech's (22UAy.DE), opens new tab cancer vaccines should start this year in Britain, marking an important step towards their possible sale on the open ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
German-based biotech company BioNTech SE is set to acquire InstaDeep, a Tunis-born and U.K.-based artificial intelligence (AI) startup, for up to £562 million (~$680 million) in its largest deal yet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results